Trials to watch: Four ALS drugs to keep an eye on
There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.
There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.
Klineo plans to expand its AI platform to include all cancers in France by the end of 2024, and eventually other countries and diseases.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Hyperfine starts enrolment in portable imaging workflow study
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
Cleerly touts new data for AI cardiovascular software
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints